Abstract
Objectives Evidence-based strategies to reduce loneliness in later life are needed because loneliness impacts all domains of health, functioning, and quality of life. Volunteering is a promising strategy, as a large literature of observational studies documents associations between volunteering and better health and well-being. However, relatively few studies have used randomized controlled trials (RCTs) to examine benefits of volunteering, and none have examined loneliness. The primary objective of the Helping Older People Engage (HOPE) study is to examine the social-emotional benefits of a social volunteering program for lonely older adults. This manuscript describes the rationale and design of the trial.
Design Randomized controlled trial examining an existing community volunteering program available nationwide. We are randomly assigning adults aged 60 or older (up to 300) who report loneliness to 12 months of either AmeriCorps Seniors volunteering program or an active control (self-guided life review). Co-primary outcomes are assessed via self-report—loneliness (UCLA Loneliness Scale) and quality of life (WHOQOL-Bref). This trial is registered at clinicaltrials.gov (NCT03343483)
Setting Lifespan of Greater Rochester, a non-medical, community-based aging services agency (volunteering) and participants’ homes (control).
Participants Adult ages ≥60 years who endorsed feelings of loneliness (score of 6 or greater on the 3-item UCLA Loneliness Scale).
Intervention The interventions are 12-months of volunteer service with the AmeriCorps Seniors program or self-guided life review writing (active control).
Measurements Data were collected at baseline, 3-, 6-, and 12-months (loneliness) and baseline and 12-months (quality of life).
Timeline Enrollment for this trial is underway and expected to finish by May 2022, with completion of follow-up assessments through April, 2023, and completion of primary outcomes soon thereafter.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT03343483
Clinical Protocols
https://clinicaltrials.gov/ct2/show/NCT03343483
Funding Statement
This research is supported by a grant from the National Institute on Aging to KVO (R01AG054457, R01AG054457-02S1). The funders have not and will not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This protocol describes a study that was reviewed and approved by the University of Rochester Research Subjects Review Board.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Not Applicable
Footnotes
This research is supported by a grant from the National Institute on Aging (R01AG054457, R01AG054457-02S1).
Data Availability
This protocol paper does not present results.
